Diabetes & Metabolism

Papers
(The TQCC of Diabetes & Metabolism is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Contents - page 173
Dapagliflozin reduces adiposity and increases adiponectin in patients with type 2 diabetes and atherosclerotic disease at short-term: An active-controlled randomised trial67
Diuretics and risk of major adverse limb events in patients with type-2 diabetes: An observational retrospective study63
Analysis of glycemic control in diabetic patients by monitoring HbA1c levels before, during and after Covid-19 confinement in Auvergne, France59
Discontinuation of hemodialysis after correction of a major hypothyroidism episode, A case report45
Editorial board42
Cost analysis of continuous glucose monitoring in patients hospitalized in a diabetes department41
SGLT2 inhibitors and the autonomic nervous system in diabetes: A promising challenge to better understand multiple target improvement38
Contents35
Editorial board35
Massive lactic acidosis and ketoacidosis with glucagon deficiency in a chronic alcoholic patient33
Prevalence and incidence of cardiovascular and renal diseases in type 1 compared with type 2 diabetes: A nationwide French observational study of hospitalized patients32
Associations of young onset age and genetic risk of beta cell dysfunction with glycaemic progression in individuals with type 2 diabetes31
Early life Bacillus Calmette-Guerin vaccination and incidence of type 1, type 2, and latent autoimmune diabetes in adulthood31
Association between adipose deposition and mortality among adults without major cardiovascular risk factors30
Association of diabetes and outcomes in patients with COVID-19: Propensity score-matched analyses from a French retrospective cohort30
Comment on “Elevated triglyceride–glucose index predicts risk of incident ischemic stroke: The Rural Chinese cohort study”28
Editorial board28
Cardiovascular protection significantly depends on HbA1c improvement with GLP-1RAs but not with SGLT2 is in type 2 diabetes: A narrative review28
Effects of SGLT2 inhibitors on clinical cancer survival in patients with type 2 diabetes27
Screening strategies for glucose tolerance abnormalities and diabetes in people with cystic fibrosis27
Eleven-year trends in socioeconomic inequalities in the prevalence and incidence of pharmacologically treated type 2 diabetes in France, 2010–202027
Association between metabolic dysfunction-associated fatty liver disease and supraventricular and ventricular tachyarrhythmias in patients with type 2 diabetes26
Concise review of lipidomics in nonalcoholic fatty liver disease26
Editorial board24
Efficacy / safety balance of DPP-4 inhibitors versus SGLT2 inhibitors in elderly patients with type 2 diabetes24
Contents24
Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?24
Sommaire24
Obesity rather than diabetes impacted severe Covid-19 on reunion island: A retrospective cohort study from a frontline hospital, 2020–202124
Could metformin modulate cardiovascular outcomes differently with DPP-4 inhibitors compared with SGLT2 inhibitors?23
1-h post-load plasma glucose for detecting early stages of prediabetes22
Objective and subjective sleep measures are associated with HbA1c and insulin sensitivity in the general population: Findings from the ORISCAV-LUX-2 study22
Prevent hypoglycaemia when using automated insulin delivery systems in type 1 diabetes requires near normal glycaemic variability21
Type B insulin resistance syndrome: A case report20
Prevalence of NAFLD, MAFLD, and MASLD: NHANES 1999-201820
Euglycaemic diabetic ketosis decompensation under dapagliflozin in a patient with MODY319
Comment on Gaudillère et al. Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme [Diabetes Metab 2021 Apr 13; 101251]19
Correspondence for “Parental history of psychiatric disorders and risk of type 1 diabetes in the offspring”19
Efficacy and safety of pharmacological treatments for gestational diabetes: a systematic review comparing metformin with glibenclamide and insulin18
Effects of elexacaftor / tezacaftor / ivacaftor triple combination therapy on glycaemic control and body composition in patients with cystic fibrosis-related diabetes18
Averaged glycaemic variability or by average: More than a simple question of wording18
Methylamine metabolites and progression to kidney failure in type 2 diabetes: an Asian and European prospective study17
HbA1c at the time of testing for gestational diabetes identifies women at risk for pregnancy complications17
Monitoring gestational diabetes mellitus patients with myDiabby Healthcare® smartphone application vs classical diary. Results from the non-inferiority TELESUR-GDM study17
Design of a prospective, longitudinal cohort of people living with type 1 diabetes exploring factors associated with the residual cardiovascular risk and other diabetes-related complications: The SFDT17
Editorial board16
Contents - Page 116
Postprandial glucose is correlated with an increasing risk of liver fibrosis in Chinese patients with nonalcoholic fatty liver disease16
Editorial board16
Age-related difference in the impact of diabetes mellitus on all-cause mortality after acute myocardial infarction15
Glycemic Risk Index (GRI) variability in type 1 diabetes adults with HbA1c ≤ 7%: Insights for clinical evaluation and intervention15
Insulin pump initiation in outpatient settings: When technology facilitates new healthcare organizations15
Do diabetic complications influence cancer-related events in people with type 2 diabetes? A cohort approach15
Effects of smoking behavior change on diabetes incidence after cancer development: A nationwide cohort study15
Transitions in metabolic health status over time and risk of heart failure: A prospective study15
Residual risk associations between initial hyperglycemia and adverse pregnancy outcomes in a large cohort including 6709 women with gestational diabetes14
Statins and clinical outcomes with COVID-19: Meta-analyses of observational studies14
The association between metformin treatment and COVID-19 outcomes according to metformin continuation during hospitalisation14
Pancreatic and gut hormone responses to mixed meal test in post-chronic pancreatitis diabetes mellitus14
Contents13
Contents - page 113
Glyburide therapy for gestational diabetes: Glycaemic control, maternal hypoglycaemia, and treatment failure13
Perirenal fat and chronic kidney disease in type 2 diabetes: The mediation role of afferent arteriolar resistance12
Association of podocyte ultrastructural changes with proteinuria and pathological classification in type 2 diabetic nephropathy12
Fewer Type A personality traits in type 2 diabetes patients with diabetic foot ulcer11
Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial design11
Acute kidney injury is associated with liver-related events in patients with metabolic dysfunction-associated fatty liver disease11
Glucagon like peptide-1 receptor agonists in type 1 diabetes11
Contents11
Editorial board11
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus11
Reduction of circulating methylglyoxal levels by a Mediterranean diet is associated with preserved kidney function in patients with type 2 diabetes and coronary heart disease: From the CORDIOPREV rand11
Diabetic ketoacidosis and mortality in COVID-19 infection10
Effect of SGLT2 inhibitors versus DPP4 inhibitors on major and non-major osteoporotic fracture risks among general and high-risk type 2 diabetes patients: A nationwide retrospective cohort study10
Risk of hospitalization and death associated with sodium glucose cotransporter-2 inhibitors: A comparison with five other classes of antidiabetic drugs10
One-hour post-load glucose is associated with biopsy-proven metabolic dysfunction-associated steatotic liver disease in obese individuals10
Association between nonalcoholic fatty liver disease and left ventricular diastolic dysfunction: A 7-year retrospective cohort study of 3,380 adults using serial echocardiography10
Trajectories of metabolic risk factors during the development of type 2 diabetes in Chinese adults10
Understanding the link between different types of maternal diabetes and the onset of autism spectrum disorders10
Effect of glucagon-like peptide 1 receptor agonists on the renal protection in patients with type 2 diabetes: A systematic review and meta-analysis10
Real-world use and effectiveness of tirzepatide among people without evidence of type 2 diabetes in the United States9
MASLD, hepatic steatosis and fibrosis are associated with the prevalence of chronic kidney disease and retinopathy in adults with type 1 diabetes mellitus9
Modification of the all-cause and cardiovascular disease related mortality risk with changes in the metabolic syndrome status: a population-based prospective cohort study in Taiwan9
Secukinumab (Anti-IL-17) induces clinical regression in early diagnosed type 1 diabetes: A case report9
Impact of different types of hypertensive disorders of pregnancy and their duration on incident post-partum risk of diabetes mellitus: Results from the French nationwide study CONCEPTION9
Renoprotective mechanisms of glucagon-like peptide-1 receptor agonists8
The progressive uncoupling of maternal insulin clearance and insulin sensitivity across gestation8
Could the development of COVID-19 vaccine-induced type 1 diabetes be explained by a simple mechanism?8
Short course corticosteroid treatment and closed-loop insulin delivery system: The experience of the DBLG1 pre-launch8
Editorial board8
Safety of sodium-glucose cotransporter 2 inhibitors in kidney transplant recipients with diabetes mellitus8
Editorial board8
Effects of remote care of patients with poorly controlled type 1 diabetes included in an experimental telemonitoring programme8
Comparisons of the risks of new-onset prostate cancer in type 2 diabetes mellitus between SGLT2I and DPP4I users: A population-based cohort study8
Glycaemic variabilities: Key questions in pursuit of clarity8
Characteristics of newly diagnosed type 1 diabetes in paediatric and adult population from Reims University Hospital, France from 1997 to 20198
0.076148986816406